Janice Bourque - 03 Jan 2022 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Reporting relationship: Director
Issuer ticker: BCYC
Reported as of: 03 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2022, 16:16:31 UTC
Next SEC filing: 05 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Lee Kalowski, Attorney-in-Fact

Key filing fact

Janice Bourque filed Form 4 for BICYCLE THERAPEUTICS plc (BCYC) on 05 Jan 2022.

Key facts

This page summarizes Janice Bourque's Form 4 filing for BICYCLE THERAPEUTICS plc (BCYC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2022, 16:16.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCYC transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCYC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 03 Jan 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,000
Exercise price: $60.87
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. The RSUs are fully vested.

Footnote F2

Each RSU represents a contingent right to receive one ordinary share.

Footnote F3

This option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .